Teva Pharmaceutical Industries Ltd (TEVA) Congress Trades

Healthcare · Generic Drugs $40.70 on Nov 2, 2026 Data as of Nov 3, 2026

Congress Trading in TEVA

10 members of Congress have disclosed 30 trades in Teva Pharmaceutical Industries Ltd (TEVA) since 2014: 13 purchases worth about $202.01K and 17 sales worth about $307.51K. The most active was Greg Gianforte, with 1 trade. The latest trade was made on Nov 13, 2020.

Trades
30
13 buys · 17 sells
Bought (est.)
$202.01K
Midpoints of the ranges
Sold (est.)
$307.51K
Net -$105.50K
Members Trading
10
6 bought · 9 sold
By Party
7 D · 23 R
Trades
Net Bought (est.)
-$105.50K
Purchases less sales
First Trade
Mar 6, 2014
Last Filed
Dec 2, 2020
Traded Nov 13, 2020

TEVA vs S&P 500, with Congress Trades

TEVA S&P 500 (SPY) Purchases Sales

TEVA’s price and SPY’s, both as the change since the start of the range. A green triangle marks a day members bought TEVA, a red one a day they sold; hover for who and how much.

All years, most trades first

10 Members Who Traded TEVA

#MemberTradesBuysSells Bought (est.)Sold (est.)Net Buys vs SPY First TradedLast Traded
1 Greg GianforteR-MT 1 1 0 $32.50K $0.00 +$32.50K +218.8% Nov 13, 2020 Nov 13, 2020
2 Donna E. ShalalaD-FL 1 0 1 $0.00 $8.00K -$8.00K – May 7, 2020 May 7, 2020
3 David E. PriceD-NC 1 0 1 $0.00 $8.00K -$8.00K – Jun 19, 2019 Jun 19, 2019
4 Francis RooneyR-FL 2 1 1 $8.00K $8.00K $0.00 -202.1% Feb 7, 2017 Aug 3, 2017
5 Cheri BustosD-IL 1 0 1 $0.00 $8.00K -$8.00K – Jan 30, 2017 Jan 30, 2017
6 James B. RenacciR-OH 10 7 3 $80.50K $97.50K -$17.00K -311.1% Apr 3, 2014 Dec 20, 2016
7 K. Michael ConawayR-TX 6 1 5 $8.00K $40.00K -$32.00K -318.0% Mar 6, 2014 Sep 12, 2016
8 Alan S. LowenthalD-CA 4 2 2 $65.00K $65.00K $0.00 -297.8% Dec 12, 2014 Sep 11, 2015
9 Thomas MacArthurR-NJ 2 1 1 $8.00K $8.00K $0.00 -302.3% Jan 6, 2015 Jan 27, 2015
10 Michael T. McCaulR-TX 2 0 2 $0.00 $65.00K -$65.00K – Jan 2, 2015 Jan 2, 2015
Newest filings first

All TEVA Trades

OwnerTypeFiling
Greg GianforteR-MTTEVATeva Pharmaceutical Industries Limited American Depositary SharesJointBuy$15K–$50KNov 13, 2020Dec 2, 202019d+328.9%+218.8%PDF
Donna E. ShalalaD-FLTEVATeva Pharmaceutical Industries Limited American Depositary SharesSelfSell$1K–$15KMay 7, 2020May 15, 20208d+252.4%+90.9%PDF
David E. PriceD-NCTEVATeva Pharmaceutical Industries Limited American Depositary SharesSelfSell$1K–$15KJun 19, 2019Jul 11, 201922d+397.6%+240.9%PDF
Francis RooneyR-FLTEVABrown Advisory - Teva Pharmaceutical Industries, Ltd. Sponsored ADRSelfSell$1K–$15KAug 3, 2017Aug 11, 20178d+71.4%-133.2%PDF
Francis RooneyR-FLTEVATeva Pharmaceutical Industries, Ltd. Sponsored ADRSelfBuy$1K–$15KFeb 7, 2017Feb 17, 201710d+26.4%-202.1%PDF
Cheri BustosD-ILTEVATeva Pharmaceutical Industries Limited American Depositary SharesSelfSell$1K–$15KJan 30, 2017Feb 9, 201710d+17.9%-212.6%PDF
James B. RenacciR-OHTEVATEVA PHARMACEUTICAL INDUSTRIES LIMITED ADR (ISRAEL)SelfSell$15K–$50KDec 20, 2016Jan 5, 201716d+12.3%-219.9%PDF
K. Michael ConawayR-TXTEVATeva Pharmaceutical Industries Limited American Depositary SharesSpouseSell$1K–$15KSep 12, 2016Oct 12, 201630d-21.1%-268.7%PDF
K. Michael ConawayR-TXTEVATeva Pharmaceutical Industries Limited American Depositary SharesSpouseSell$1K–$15KMay 11, 2016Jun 3, 201623d-20.1%-284.3%PDF
K. Michael ConawayR-TXTEVATeva Pharmaceutical Industries Limited American Depositary SharesSpouseSell$1K–$15KMay 4, 2016Jun 3, 201630d-24.4%-291.3%PDF
James B. RenacciR-OHTEVATEVA PHARMACEUTICAL INOUSTRIES LIMITED ADR (ISRAEL)SelfBuy$1K–$15KJan 12, 2016Feb 25, 201644d-36.8%-325.2%PDF
James B. RenacciR-OHTEVATEVA PHARMACEUTICAL INDUSTRIES LIMITED ADR (ISRAEL)SelfSell$15K–$50KOct 22, 2015Nov 13, 201522d-27.3%-293.7%PDF
Alan S. LowenthalD-CATEVATeva Pharmaceutical Industries Limited American Depositary SharesSpouseSell$15K–$50KSep 11, 2015Sep 18, 20157d-36.1%-318.4%PDF
Alan S. LowenthalD-CATEVATeva Pharmaceutical Industries Limited American Depositary SharesSpouseSell$15K–$50KJul 27, 2015Aug 5, 20159d-43.5%-307.2%PDF
James B. RenacciR-OHTEVATEVA PHARMACEUTICAL INDUSTRIES LIMITED ADR (ISRAEL)SelfSell$15K–$50KJul 13, 2015Jul 22, 20159d-35.7%-294.3%PDF
15 more trades Create a free account to keep reading every disclosed trade.
Showing 1–15 of 30 trades Filings: Clerk of the House

Tip. Hover a row for the filing’s full asset text and comments; the PDF link opens the report itself.

About Congress Trades in TEVA

Which members of Congress trade TEVA?

10 members of Congress have disclosed 30 trades in Teva Pharmaceutical Industries Ltd (TEVA) since 2014: 13 purchases worth about $202.01K and 17 sales worth about $307.51K. The most active was Greg Gianforte, with 1 trade. The latest trade was made on Nov 13, 2020. Most active: Greg Gianforte (1), Donna E. Shalala (1), David E. Price (1), Francis Rooney (2), Cheri Bustos (1).

Are members of Congress buying or selling TEVA?

Since 2014 they have disclosed 13 purchases and 17 sales; by the midpoints of the disclosed ranges, about $202.01K bought and $307.51K sold, a net sale of $105.50K.

How are these trades disclosed?

Members of Congress report each trade over $1,000 within 45 days under the STOCK Act, with the amount as a range. The chart marks the days members traded TEVA on its price, against the S&P 500 over the same days.

More on Teva Pharmaceutical Industries Ltd

Members of Congress disclose trades as dollar ranges, up to 45 days after the trade and sometimes later. Volumes use the midpoints of those ranges and are estimates; portfolio figures are a model built from the disclosed trades, not the members’ actual accounts. Not investment advice.